- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT01147952
The Effect of Exercise on Peripheral Blood Gene Expression in Angina
A Randomised Trial of the Effect of Exercise on Peripheral Blood Gene Expression in Patients With Stable Angina
Regular exercise is known to produce significant health benefits and to reduce the risk of heart diseases, although how this benefit occurs is not well understood. White blood cells are known to be involved in triggering heart attacks, and which genes are switched on or off in white blood cells determines whether they have beneficial or harmful effects. Previous studies, and studies ongoing in our group, have demonstrated measurement of peripheral blood gene expression (which reflects white blood cell gene expression) is able to distinguish between patients with and without coronary artery disease, or patients who are able to develop good compared with poor coronary collateral arteries. Therefore, the gene expression signature in peripheral blood may provide novel diagnostic or prognostic information, and insight into the pathogenesis of heart disease.
We therefore hypothesise that exercise alters peripheral blood gene expression in patients with coronary artery disease and angina. This will identify possible ways that exercise improves angina and reduces the risk of heart disease.
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Type d'étude
Inscription (Réel)
Phase
- N'est pas applicable
Contacts et emplacements
Lieux d'étude
-
-
South Yorkshire
-
Sheffield, South Yorkshire, Royaume-Uni, S5 7AU
- NIHR Cardiovascular Biomedical Research Unit
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- Class I to III angina pectoris (classified according to the Canadian Cardiovascular Society [CCS])with documented myocardial ischemia or coronary artery disease on angiography
- Ability to read and speak English to a level allowing satisfactory completion of written questionnaires and to understand instruction during the exercise programme.
Exclusion Criteria:
- Acute coronary syndromes or recent myocardial infarction (<2 months)
- Left main coronary artery stenosis >25% or high-grade proximal left anterior descending artery stenosis
- Known reduced left ventricular function (ejection fraction <40%)
- Significant valvular heart disease
- Insulin-dependent diabetes mellitus
- Occupational, orthopedic, and other conditions that preclude regular exercise
- Patients whose ECG prevents interpretation of an exercise test (LBBB, RBBB, pacemaker implantation).
- Patients who already perform greater than 30min continuous exercise three times weekly (self-reported).
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Science basique
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: 12 week exercise training
|
randomised to 12 weeks of exercise training up to three times weekly.
Training will be interval training with active recovery, with 3 min intervals conducted 10bpm below angina threshold.
|
|
Aucune intervention: Conventional Care
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Délai |
|---|---|
|
Peripheral blood gene expression
Délai: baseline
|
baseline
|
|
Peripheral blood gene expression
Délai: 6wks after starting 12week exercise training (or conventional care)
|
6wks after starting 12week exercise training (or conventional care)
|
|
peripheral blood gene expression
Délai: 12 weeks after exercise training (or conventional care)
|
12 weeks after exercise training (or conventional care)
|
|
Peripheral blood gene expression
Délai: 24 weeks after starting 12 weeks exercise training programme
|
24 weeks after starting 12 weeks exercise training programme
|
Mesures de résultats secondaires
Mesure des résultats |
Délai |
|---|---|
|
Angina status
Délai: baseline
|
baseline
|
|
Angina status
Délai: 6wks after starting 12 week exercise programme (or conventional care)
|
6wks after starting 12 week exercise programme (or conventional care)
|
|
Angina status
Délai: 12wks after starting 12 week exercise programme (or conventional care)
|
12wks after starting 12 week exercise programme (or conventional care)
|
|
Angina Status
Délai: 24wks after starting 12 week exercise programme (or conventional care)
|
24wks after starting 12 week exercise programme (or conventional care)
|
|
Anxiety Score
Délai: baseline
|
baseline
|
|
Anxiety Score
Délai: 6wks after starting 12 week exercise programme (or conventional care)
|
6wks after starting 12 week exercise programme (or conventional care)
|
|
Anxiety Score
Délai: 12wks after starting 12 week exercise programme (or conventional care)
|
12wks after starting 12 week exercise programme (or conventional care)
|
|
Anxiety Score
Délai: 24wks after starting 12 week exercise programme (or conventional care)
|
24wks after starting 12 week exercise programme (or conventional care)
|
|
Depression Score
Délai: 6wks after starting 12 week exercise programme (or conventional care)
|
6wks after starting 12 week exercise programme (or conventional care)
|
|
Depression Score
Délai: baseline
|
baseline
|
|
Depression Score
Délai: 12wks after starting 12 week exercise programme (or conventional care)
|
12wks after starting 12 week exercise programme (or conventional care)
|
|
Depression Score
Délai: 24wks after starting 12 week exercise programme (or conventional care)
|
24wks after starting 12 week exercise programme (or conventional care)
|
Collaborateurs et enquêteurs
Publications et liens utiles
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Estimation)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Estimation)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- STH15565
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .